NEW YORK--(BUSINESS WIRE)--
The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Tobira Therapeutics, Inc. (“Tobira”) (NASDAQ:TBRA) stock prior to September 20, 2016.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Tobira to Allergan plc for $28.35 per share. The deal also includes up to $49.84 per share in Contingent Value Rights, payable upon the successful completion of certain milestones. The deal has a potential approximate value of $1.695 billion. To learn more about the action and your rights, go to:
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160921006122/en/
